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Abstract
Background: In April 2009, a new strain of H1N1 influenza virus, referred to as pandemic influenza A (H1N1) was
first detected in humans in the United States, followed by an outbreak in the state of Veracruz, Mexico. Soon
afterwards, this new virus kept spreading worldwide resulting in a global outbreak. In China, the second Circular of
the Ministry of Health pointed out that as of December 31, 2009, the country’s 31 provinces had reported 120,000
confirmed cases of H1N1.
Methods: We formulate an epidemic model of influenza A based on networks. We calculate the basic
reproduction number and study the effects of various immunization schemes. The final size relation is derived for
the network epidemic model. The model parameters are estimated via least-squares fitting of the model solution
to the observed data in China.
Results: For the network model, we prove that the disease-free equilibrium is globally asymptotically stable when
the basic reproduction is less than one. The final size will depend on the vaccination starting time, T, the number
of infective cases at time T and immunization schemes to follow. Our theoretical results are confirmed by
numerical simulations. Using the parameter estimates based on the observation data of the cumulative number of
hospital notifications, we estimate the basic reproduction number R0 to be 1.6809 in China.
Conclusions: Network modelling supplies a useful tool for studying the transmission of H1N1 in China, capturing
the main features of the spread of H1N1. While a uniform, mass-immunization strategy helps control the
prevalence, a targeted immunization strategy focusing on specific groups with given connectivity may better
control the endemic.
Introduction
In April 2009, a new strain of H1N1 influenza virus,
referred to as influenza A (H1N1), was first detected in
humans in the United States followed immediately by
an outbreak in the state of Veracruz, Mexico. Since
then, this new virus has kept spreading worldwide caus-
ing a global outbreak. As of December 20, 2009, it was
reported by WHO that more than 208 countries and
territories experienced the pandemic resulting in at least
11,516 deaths [1]. In China, the Circular of the Ministry
of Health of the People’s Republic of China pointed out
that as of December 31, 2009, the 31 provinces had
reported 120,498 confirmed cases of H1N1 [2] . Of
these confirmed cases, 118,244 had recovered, while 648
died. However, actual number of cases of people
infected with the new virus is likely to be much higher
than these numbers suggest, as most cases are not
tested. Figure 1 shows the number of reported cases of
H1N1 in China since June 2009. Similar to other influ-
enza viruses, pandemic H1N1 typically results from per-
son-to-person transmission through respiratory droplets
generated by coughing and sneezing [3]. Symptoms
usually last 4-6 days [4]. The infectious period for a con-
firmed case is defined as 1 day prior to the onset of
symptoms to 7 days after onset. For a more detailed
description of H1N1, see the Center for Disease Control
and Prevention (CDC) [3], World Health Organization
(WHO) [1], and Medscape’s H1N1 Influenza A (Swine
Flu) Alert Center [4].
The H1N1 pandemic calls for action, and various
mathematical models have been constructed to
study the spread and control of H1N1. Fraser et al.
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range of 1.4 to 1.6 by analyzing the outbreak in Mex-
ico, and earlier data of the global spread [6]. Nishiura
et al. also estimated the reproduction number R0 but
in the range of 2.0 to 2.6 for Japan [7]; they also esti-
mated the reproduction number as 1.96 for New Zeal-
and [8]. Vittoria Colizza et al. used a global epidemic
and mobility model to obtain the estimation of the size
of the epidemic in Mexico as well as that of imported
cases at the end of April, 2009 [9]. Marc Baguelin et
al. presents a real-time assessment of the effectiveness
and cost-effectiveness of alternative influenza A
(H1N1) vaccination strategies by a dynamic model
[10]. H1N1, like many other infectious diseases, is
intrinsically related to human social networks; it exhi-
bits great heterogeneity in terms of the numbers and
the pattern of contacts. The usual compartmental
modelling in epidemiology generally assumes that
population groups are fully and homogeneously mixed,
but this does not reflect the real situation of the varia-
tion in the process of contact transmission. The epi-
demic modelling on complex networks has been
attracting great interest, and various epidemic models
on complex networks have been extensively investi-
gated in recent years [11-17].
The network model and parameters
Based on the spreading process of H1N1, we propose an
SEIAR model by classifying the population as suscepti-
ble (S), exposed (E), asymptomatically infected (A),
symptomatically infected (I) and removed/immune (R).
The asymptomatically infected compartment contains
those who fail to show noticeable symptoms or with
light flu-like symptoms; they are not identified as H1N1
cases, but are able to spread the infection. We assume
that a susceptible individual becomes infected if they
come into contact with an asymptomatically or sympto-
matically infective individual. Then, the susceptible
enters the exposed class E of those in the latent period.
The period of incubation for H1N1 is 1-3 days [3]. After
the latent period, the individual enters the class I or A
of infectives, who are infectious in the sense that they
are capable of transmitting the infection. When the
infectious period ends, the individual enters the recov-
ered class R. We assume that a removed individual will
never become susceptible or infected again. In our
model, new births, natural deaths and migrations are
ignored. The flow diagram of the individuals is depicted
in Figure 2.
In contrast to classical compartment models, we con-
sider the whole population and their contacts in networks.
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Figure 1 The data of the Influenza A infection in China. The data of the influenza A infection in China reported by Chinese CDC from June
1 to November 22, 2009.
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Page 2 of 9Each individual in the community can be regarded as a
vertex in the network, and each contact between two indi-
viduals is represented as an edge (line) connecting the ver-
tices. The number of edges emanating from a vertex —
that is, the number of contacts a person has — is called
t h ed e g r e eo ft h ev e r t e x .T h e r e f o r e ,w ea s s u m et h a tt h e
population is divided into n distinct groups of sizes Nk (k
=1 ,2 ,…, n) such that each individual in group k has
exactly k contacts per day. If the whole population size is
N (N = N1+N 2 +. . .+Nn), then the probability that a uni-
formly chosen individual has k contacts is P(k)=Nk/N,
which is called the degree distributions of the network.
Empirical studies have shown that many real networks
have scale-free (SF) degree distributions P(k) ≈ k
–g with 2
≤ g ≤ 3 where the epidemic model does not show an epi-
demic threshold (see [18]) and Poisson degree distribu-
tions P(k)=µ
k/k!e x p ( –µ) (see [19]). If Sk , Ek, Ak, Ik and Rk
represent the number of susceptible, exposed, asymptoma-
tically infected, symptomatically infected and recovered
individuals within group k (where Sk + Ek + Ak + Ik + Rk =
Nk), then the following system of differential equations
captures disease spread for arbitrarily large networks (N
® ∞), for both transmission through the network and the
mean-field type transmission
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 and 
represent the expectation that any given edge points to
an infected and asymptomatically infected vertex respec-
tively. Note that dS
dt
dE
dt
dA
dt
dI
dt
dR
dt
kkk kk ++++= 0;
thus, Sk(t)+Ek(t)+Ak(t)+Ik(t)+Rk(t)=Nk is constant.
The densities of susceptible, exposed, asymptomatically
infected, symptomatically infected and recovered nodes
of degree k at time t, are denoted by sk, ek, ak, ik and rk,
respectively. If Sk, Ek, Ak, Ik and Rk are used to represent
sk, ek, ak, ik,a n drk respectively, we can still use system
(1)-(5) to describe the spread of disease on the network.
Clearly, these variables obey the normalization condition
Sk + Ek + Ak + Ik + Rk = 1, and also
ΘΘ
A
k
k
I
k
k
t
k
kP k A t t
k
kP k I t () = () () () = () () ∑∑
11
, .       
All parameters are positive constants and we summarize
them in Table 1.
The mathematical formulation of the epidemic modelling
on the network is completed with the initial conditions
given as Sk(0) = Sk0, Ik(0) = Ik0, Ek(0) = Ak(0) = Rk(0) = 0.
Analysis
Stability and basic reproduction number
One can verify that system (1)-(5) has a unique infection-
free equilibrium P
0 ( 1 ,. . .,1 ,. . ., 1 ,0 ,0 ,. . .,0 ) .F o l l o w i n g
6 (
,
$
5
Figure 2 The model. Flow diagram of the transmission. Individuals may be Susceptible, Exposed, Asymptomatic, Infected or Recovered.
Table 1 Parameters of the model
Parameters description
l1 transmission coefficient between community Sk and Ai
l2 transmission coefficient between community Sk and Ii
δ rate of becoming infectious after latentcy
g rate of becoming asymptomatically infected
1 – g rate of becoming symptomatically infected
a1 recovery rate of asymptomatically infected
a2 recovery rate of symptomatically infected
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Page 3 of 9van den Driessche and Watmough [20], we note that only
compartments Ek, Ak and Ik are involved in the calcula-
tion of R0. In the infection-free state P
0,t h er a t eo f
appearance of new infections F and the rate of transfer of
individuals out of the two compartments V are given by
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Using the concepts of next-generation matrix [20], the
reproduction number is given by R0 = r(FV
–1), the
spectral radius of the matrix FV
–1.
To determine the spectral radius of FV
–1,w ef i r s t
represent the inverse of V by the following matrix:
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Setting C = FV
–1, we have
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Now we are ready to compute the eigenvalues of the
matrix C = FV
–1.
Obviously, C and C
n n
11
× have the same spectral radius.
Since matrix C
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× has rank 1, the spectral radius
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Therefore, we obtain the reproductive number
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In summary, we have the following theorem.
Theorem 1 If R0 < 1, the infection-free equilibrium P
0
(1, ... , 1, ... , 1, 0, 0, ... , 0) of system (1)-(5) is locally
asymptotically stable, and if R0 > 1 the infection-free
equilibrium P
0 is unstable.
Next, we will prove the global asymptotic stability of
the infection-free equilibrium.
Theorem 2 If R0 < 1, the infection-free equilibrium P
0
( 1 ,. . .,1 ,. . .,1 ,0 ,0 ,. . .,0 )o fs y s t e m( 1 ) - ( 5 )i sg l o b a l
asymptotically stable.
Proof. Let us consider the Lyapunov function of the
form:
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Page 4 of 9We now compute the time derivative of L(t) along the
solutions of system (1)-(5). It is seen that
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Furthermore, L′(t)=0o n l yi fAk = Ik = 0. Therefore,
the global stability of P
0 when R0 <1f o l l o w sf r o m
LaSalle’s Invariance Principle [21].
Estimation of parameters
To calculate the basic reproduction number for the
H1N1 epidemic in China and to explore the transient
dynamics of the transmission under different vaccination
schemes, we need to estimate the model parameters. In
general, parameters of a model as system (1)-(5) can be
estimated via least-squares fitting of the model solution
to the observed data i(t) [22-24]. In other words, we are
looking for the set of parameters Λ =( l1, l2, g, δ, a1,
a2) such that the associated model solution best fits the
epidemic data by minimizing the sum of the squared
differences between the observed data i(t)a n dt h et o t a l
number NP k I t
k
n
k = ∑ 1
() (). Therefore, we need to mini-
mize the objective function:
Yi t N P k I t k
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where nd represents the number of days we choose
from the observed data.
In the real world, P(k) usually obeys a power-law dis-
tribution. Hence, P(k)=2 m
2k
–ν (m =3a n dν =3 .5) is
used in model (1)-(5).
For the estimation of parameters, accurate data are
essential. Due to the complexity of the spreading of
H1N1 and adjustment of control strategics in China,
official data are not available for our modeling studies.
Luckily, for the period from August 9th to September
2nd, the reported infected data contain useful informa-
tion: the number of the infected and recovered classes
from the daily data. The data reported in this period
are almost continuous, and there is no vaccination in
this time period. Therefore, we use the data collected
from August 9th to September 2nd in China to esti-
mate the parameters of model (1)-(5). For the simula-
tions, we set the step size as Δt =0 .04. By using Euler
and the advanced alternate directions scheme [22], we
estimate the parameters and summarize them in Table
2. Using the parameters in Table 1, a straightforward
computation using formula (6) gives the basic reproduc-
tive number for the H1N1 epidemic in China as R0 =
1.6809. Using the parameters in Table 2, we compared
the model simulation results with the observation data in
Figure 3. It can be seen that our model captures the
main features of the spread of the H1N1 in China.
The effect of vaccination strategies
Vaccination is very powerful in controlling influenza. In
this section, we will discuss the impact of various immu-
nization schemes.
Uniform immunization strategy
Uniform immunization strategy is the simplest immuni-
zation schemes [14,25,26]. Using p for the immunization
rate (0 <p < 1), by substituting l1® (1 – p)l1 and l2®
(1 – p)l2 in model (1)-(5), the model becomes
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We obtain the critical fraction pc for the prevention
and control of the prevalence of H1N1 as pR c =−
− 1 0
1.
For the case of China, this is pc =− = 1
1
1 6809
04 0 5
.
. .
In other words, in order to control the prevalence, at
least 40% of the whole susceptible population would
have to be immunized through vaccination (about 536
million individuals).
Table 2 Parameters estimated from the observed data in
China
Parameters Estimated value
l1 0.01
l2 0.188
δ 0.4
g 0.85
a1 0.141
a2 0.141
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Page 5 of 9Targeted immunization
Another effective strategy is the targeted immunization
[25,26]. For the network, we introduce lower and upper
thresholds 1 and 2, such that if k >2,a l ln o d e sw i t h
connectivity k are immunized, while if 1 <k <2, pk (0
<pk ≤ 1) portion will be immunized, and pk is defined as
the fraction of individuals to be immunized, i.e., we
define the immunization rate sk as
 kk P
kK
Kk
kK
K =
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⎨
⎪
⎩
⎪
>
<
<
<
1
0
2
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   ,
(7)
where  =∑ k
k
P k ( ) is the average immunization
rate. The epidemic model (1)-(5) now becomes
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We then calculate the reproductive number to obtain
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where, for convenience, we set pk = p in model (7).
We plot R0 as a function of k2 and p in Figure 4. One
can see from this figure that R0 is an increasing function
of k2 but a decreasing function of p. In other words, if p
is large or k2 is small, more people receive vaccination,
then H1N1 can be controlled.
The final size relation
First, we show that for the model (1)-(5) the disease will
eventually die out, i.e., A(∞)=0 ,E(∞) = 0, and I(∞)=0 .
Note that the positive orthant is invariant, so all solu-
tions of model (1)-(5) remain non-negative and bounded
in the set defined by Sk, Ak, Ik, Rk ≥ 0 and Sk +A k +I k +
Rk = 1. Observing that
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dt
st Et Et kk k (( ) ( ) ) ( ), += −  (9)
we see that Sk(t)+Ek(t) is decreasing whenever Ek >0 .
However, Sk + Ek is bounded below by 0; hence, it has a
limit. Moreover, model (1)-(5) implies that St Et kk
′′ + () ()
is bounded because Ek(t) is bounded. Hence
lim( ( ) ( ))
t
kk St Et
→∞
′′ += 0 ,s oEk(∞) = 0. Similarly, we can
prove that A(∞)=0a n dI(∞) = 0. We adopt the conven-
tion that, for an arbitrary continuous function w(t)w i t h
non-negative components, ww t w w t dt
t
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we integrate the seventh equation from t =0t o∞,w eh a v e
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The left-hand side of (10) is finite because the compo-
nents of Sk(0), Sk(∞), Ek(0) and Ek(∞)a r eb o u n d e db y
the initial total population size. Therefore, the right-
hand side of (10) is also finite and δ is positive. Since Ek
(∞) = 0, we have
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The final size without vaccination
Integration of equation (1)) from 0 to t gives
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If Sk(0) = Sk0, Ik(0) = Ik0, Ek(0) = Ak(0) = 0, then the
final size relation becomes
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P(k)=2 m
2k
–v (m = 3 and ν =3 .5).
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The final size with vaccination
If vaccination follows a uniform immunization strategy,
we have
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To fully see the effect of vaccination, we show that the
final size of susceptible, recovered and vaccinated indivi-
duals. It can be seen from Figure 5 that the final size of
the susceptible and vaccinated increase as p increases.
However, the final size of the recovered is a decreasing
function of p.
If vaccination is a targeted immunization, the final size
relation becomes
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The final size with vaccination from time T
If the vaccination strategy from time T follows a tar-
geted immunization scheme, integration of equation (1)
from 0 to T and integration of equation (8) from T to t
(t >T) gives
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with targeted immunization scheme from time T
ln
()
()
() () () () (
S
S
k
k
kP k A t dt
k
k
kP k I t dt k
k k
k
k
k
0 12
0
1 ∞
=+ − ∑ ∫ ∑
∞ 
k k
I
k
I
T
kk
k
kk d t
R
k
k
kP k S S R
k
k
kP k
ΘΘ +
=− ∞ +
∞ ∞
∫ ∫
∑
 2
0
0 2 0 2 0
)
() ( () ( ) ) () )( ) ( )( )
()
() ()
E
k
k
kP k A
k
k
kP k I
k
k
k
k
k
k
k
0 0
1
0
1
1
2
2
1
+
+
−
−
∑∑
∑




 k k
kk k k
k
k
k
kP k S T S E T A T
k
k
kP k




1
2
2
1
() (( () () () ) () )
( )((
−∞ + +
−−
∑
 ) ( () () () ) () ) . ST S ET IT kk k k
k
−∞ + + ∑
0 0.2 0.4 0.6 0.8 1
1.2
1.22
1.24
1.26
1.28
1.3x 10
9
p
S
(

)
0 0.2 0.4 0.6 0.8 1
0
2
4
6
8
10x 10
7
p
R
(

)
0 0.2 0.4 0.6 0.8 1
0
5
10
15x 10
8
p
V
(

)
Figure 5 The final sizes for susceptible, recovered and vaccinated population. The final sizes of the susceptible, recovered and vaccinated are
plotted as a function of p. We use parameters l1 =0 .01, l2 =0 .188, δ =0 .4, a1 = a2 =0 .141, g =0 .85 and P(k)=2 m
2k
–ν (m = 3 and ν =3 .5).
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Network models can capture the main features of the
spread of the H1N1. In this paper, using a network epi-
demic model for influenza A (H1N1) in China, we cal-
culated the basic reproduction number R0 and
discussed the local and global dynamical behaviors of
the disease-free equilibrium. The effects of various
immunization schemes were studied and compared. A
final size relation was derived for the network epidemic
models. The derivation depends on an explicit formula
for the basic reproduction number of network disease
transmission models. The transmission coefficients are
estimated through least-squares fitting of the model to
observed data of the cumulative number of hospital
notifications. We also gave the estimated value for the
reproduction number for influenza A (H1N1) in China
as R0 =1 .6809.
Parameters were estimated during the period when
the vaccination was not applied. For these parameters,
we found that g =0 .85, which means that 15% of the
exposed become infected during the early course of the
endemic. Although vaccination commenced in China in
November 2009, we were not able to compare the real
data with the model projections due to lack of data.
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